share_log

Canaccord Genuity Maintains Hold on Immunocore Hldgs, Raises Price Target to $67

Benzinga ·  May 9 14:53

Canaccord Genuity analyst Bill Maughan maintains Immunocore Hldgs (NASDAQ:IMCR) with a Hold and raises the price target from $63 to $67.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment